Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHemical OptImization of Cerebral Embolectomy in Patients With Acute Stroke Treated With Mechanical Thrombectomy 2 (CHOICE 2 TRIAL)

NCT05797792 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.

NCT NCT05797792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05797792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHemical OptImization of Cerebral Embolectomy in Patients With Acute Stroke Treated With Mechanical Thrombectomy 2 (CHOICE 2 TRIAL)
Lead sponsor
Hospital Clinic of Barcelona
Phase
Phase 3
Overall status
Completed
Start date
November 18, 2023
Completion date
November 14, 2025
Enrollment
440 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute, stroke, acute ischemic